Seeking Alpha

Thomas Garrity

Thomas Garrity
Send Message
View as an RSS Feed
View Thomas Garrity's Comments BY TICKER:
Latest  |  Highest rated
  • Positive Divergence Is A Buy Signal For MoSys [View article]
    Execution in the form of BE-1-2 delivery to end customers (OEM's) is what's must happen here. As you know in technology, a design in affirms that production orders can be anticipated with a degree of certainty. However its the actual realization of volume unit shipments which confirms product is in traction mode. I'd love to see a EZ_CHIP (EZCH) rewind and play with MOSY here. Glowing articles will not speed up sales cycle.
    Dec 9, 2013. 03:36 PM | Likes Like |Link to Comment
  • Positive Divergence Is A Buy Signal For MoSys [View article]
    The write ups end up to be overkill. And the rally's never build a footing with shareholder base- just trader footprints are left behind!
    Dec 9, 2013. 11:50 AM | Likes Like |Link to Comment
  • Positive Divergence Is A Buy Signal For MoSys [View article]
    P=man is a perpetual buyer- what he needs to improve upon is production runs for BE's..................... give investors a 360 wrap around of what the number of pieces per card and $'s to expect!!
    Dec 9, 2013. 11:42 AM | Likes Like |Link to Comment
  • Positive Divergence Is A Buy Signal For MoSys [View article]
    Will this be more than just another Seeking Alpha Walmart price roll-back rally?
    Dec 9, 2013. 11:29 AM | Likes Like |Link to Comment
  • Why Authentidate's Management Is Bullish [View article]
    I've been eying this one, but I can't see any product traction beyond the VA? You can mention tele-health/medicine all day long I.e Beat and others. However, show me articles about how powerful this company's offering is being viewed by leaders in space and or customers?

    I want to be interested- point me in the direction of the noise coming from the money factory?
    Dec 6, 2013. 01:37 PM | Likes Like |Link to Comment
  • What Do Analyst Upgrades And Coverage Mean For QuickLogic? [View article]
    Do these guys have a vested interest in being bullish on Quick?

    Roth Capital Partners is serving as the sole book-running manager for the Offering and The Benchmark Company is acting as co-manager.

    Secondly, Next Inning (a good outfit) has been long in the tooth for Quick since Qualcomm, and the Snap Dragon days.

    Quick has always been on the cusp of the next wave in technology, but somehow the products (surfer) never get integrated (hits the tube).

    Sure, one could say that Samsung is the barrel of the wave. However, give me some more product traction vs "the next wave coming in will be the monster one"

    I'm forever loving Quick. But the relationship must be 50/50 and result in sustainable sales to cover: legacy fallout and sporadic design wins, which may/may not lead to production orders?
    Dec 6, 2013. 12:36 PM | 1 Like Like |Link to Comment
  • Yo Dude, 'AudioCodes Got Dell' [View article]
    I'll go with MOSY- I don't see AUDC as a growth company (looking at revenue and legacy products).
    Dec 6, 2013. 09:49 AM | Likes Like |Link to Comment
  • 4 Stocks To Double In 2014 [View article]
    Like the Energizer Bunny
    Nov 25, 2013. 08:10 PM | 3 Likes Like |Link to Comment
  • Horizon Pharma's Unsustainable Business Model [View article]
    Glad I listened to your opinion on HZNP!!
    Nov 19, 2013. 09:44 AM | Likes Like |Link to Comment
  • Reed's: 50% Potential Upside - Kombucha Is The Best Thing Since Craft Beer In Beverage Industry [View article]
    In order to grab onto Kombucha and other Reed's products, contact Reeds directly via their website for locations in your area. In the interim, here is a video from YouTube (hosted on Snoop Dog's (Lion/Cat/Tigers?) site)) to familiarize yourself with the Kombucha line.
    Nov 14, 2013. 07:12 AM | Likes Like |Link to Comment
  • Multi-Bagger Potential As iCAD Nears A Pivotal Inflection Point [View article]
    Can you give a qualitative opinion on the competition both Mobetron and Intraoptic Medical vs IORT product?
    Nov 11, 2013. 12:46 PM | Likes Like |Link to Comment
  • Zogenix Is Vastly Over-valued Even With FDA Approval [View article]
    Is it possible Zohydro w/o acetaminophen is a blessing for those who cannot tolerate Tylenol pain reliever overdosing /renal issue?
    Nov 10, 2013. 04:58 PM | 2 Likes Like |Link to Comment
  • Reed's: 50% Potential Upside - Kombucha Is The Best Thing Since Craft Beer In Beverage Industry [View article]
    Subliminally, Reed's has pushed ahead with the ginger agenda with their new Kombucha products. To continually press down on the strings of the core ginger brands vs going after the more lucrative Kombucha market would be like choosing to take down an elephant with a pea shooter versus using a dart gun. Because the Kombucha beverage category, offers far better growth rates than ginger could ever expect to deliver and eventually, the K-line will contribute to Reed's earning expansion. Remember, Kombucha beverage is in its infancy. I can go into about any grocery store and ask where's the Kombucha hiding and get the same rolling eyes of unfamiliarity with the product. What's shocking is, these same blank responses to K inquiries are happening in stores that carry the product, On the whole, it will take time to build Kombucha product recognition. And the Reed's brand is not exempt from these Kombucha state of affairs, relative to consumer awareness of product existence and its availability. Since, Reed's has a huge distribution network for Kombucha already in place, inherently they have a leveraged opportunity to carve out the Kombucha niche, faster than say a new entrant without the same infrastructure. In addition, (in the not so distant future) Reed's will likely partner with a major beverage company in order to expedite widespread emptor attention to the Reed's name in Kombucha and also to educate the public's understanding of the Kombucha category in general. We've always known that behind each/every Reed's product development effort there is underlining genius at work. However, its time to summon a viable marketing force much larger than Reed's itself (a behemoth beverage company I.e Coke/Pepsi) to capitalize further on this superior product creativity and to bring the company faster/deeper into profitability.
    Nov 10, 2013. 01:02 PM | Likes Like |Link to Comment
  • Lionbridge Still Not Living Up To Its Potential [View article]
    Crowd Sourcing looks huge!!
    Nov 10, 2013. 12:44 PM | Likes Like |Link to Comment
  • Reed's: 50% Potential Upside - Kombucha Is The Best Thing Since Craft Beer In Beverage Industry [View article]
    There hasn't been extensive clinical work in the area of how
    Kombucha regulates the immune system? Certainly, the Chinese have observed/known (before BC time) about the ability of probiotics to destroy dangerous levels of harmful microbes in the digestive track. With $327 mil in sales for 2017, Kombucha is certainly a drink to own. Especially, when the CAGR for Kombucha probably exceeds growth rates in all of beverage categories combined.
    Nov 9, 2013. 02:08 PM | Likes Like |Link to Comment